Logo image of 5Q5.DE

SNOWFLAKE INC (5Q5.DE) Stock Fundamental Analysis

FRA:5Q5 - US8334451098 - Common Stock

189.54 EUR
+1.24 (+0.66%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, 5Q5 scores 4 out of 10 in our fundamental rating. 5Q5 was compared to 71 industry peers in the IT Services industry. 5Q5 has a bad profitability rating. Also its financial health evaluation is rather negative. 5Q5 is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 5Q5 was profitable.
In the past year 5Q5 had a positive cash flow from operations.
In the past 5 years 5Q5 always reported negative net income.
Of the past 5 years 5Q5 4 years had a positive operating cash flow.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

5Q5 has a Return On Assets of -16.83%. This is amonst the worse of the industry: 5Q5 underperforms 85.92% of its industry peers.
Looking at the Return On Equity, with a value of -58.16%, 5Q5 is doing worse than 85.92% of the companies in the same industry.
Industry RankSector Rank
ROA -16.83%
ROE -58.16%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

The Gross Margin of 5Q5 (66.60%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of 5Q5 has grown nicely.
The Profit Margin and Operating Margin are not available for 5Q5 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

3

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 5Q5 has about the same amount of shares outstanding.
The number of shares outstanding for 5Q5 has been increased compared to 5 years ago.
The debt/assets ratio for 5Q5 is higher compared to a year ago.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

The Debt to FCF ratio of 5Q5 is 3.10, which is a good value as it means it would take 5Q5, 3.10 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.10, 5Q5 is in line with its industry, outperforming 54.93% of the companies in the same industry.
5Q5 has a Debt/Equity ratio of 0.96. This is a neutral value indicating 5Q5 is somewhat dependend on debt financing.
5Q5's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. 5Q5 is outperformed by 64.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 3.1
Altman-Z N/A
ROIC/WACCN/A
WACC8.91%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.48 indicates that 5Q5 should not have too much problems paying its short term obligations.
5Q5 has a better Current ratio (1.48) than 67.61% of its industry peers.
A Quick Ratio of 1.48 indicates that 5Q5 should not have too much problems paying its short term obligations.
5Q5's Quick ratio of 1.48 is fine compared to the rest of the industry. 5Q5 outperforms 76.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

5Q5 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.48%, which is quite good.
Measured over the past years, 5Q5 shows a very strong growth in Earnings Per Share. The EPS has been growing by 334.45% on average per year.
Looking at the last year, 5Q5 shows a very strong growth in Revenue. The Revenue has grown by 28.37%.
Measured over the past years, 5Q5 shows a very strong growth in Revenue. The Revenue has been growing by 68.78% on average per year.
EPS 1Y (TTM)18.48%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%94.44%
Revenue 1Y (TTM)28.37%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%31.78%

3.2 Future

The Earnings Per Share is expected to grow by 39.35% on average over the next years. This is a very strong growth
Based on estimates for the next years, 5Q5 will show a very strong growth in Revenue. The Revenue will grow by 23.42% on average per year.
EPS Next Y37.91%
EPS Next 2Y39.71%
EPS Next 3Y43.44%
EPS Next 5Y39.35%
Revenue Next Year25.9%
Revenue Next 2Y24.52%
Revenue Next 3Y25.09%
Revenue Next 5Y23.42%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

5Q5 is valuated quite expensively with a Price/Earnings ratio of 203.81.
76.06% of the companies in the same industry are cheaper than 5Q5, based on the Price/Earnings ratio.
5Q5's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.06.
With a Price/Forward Earnings ratio of 138.52, 5Q5 can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 5Q5 is valued a bit more expensive than the industry average as 70.42% of the companies are valued more cheaply.
5Q5's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.69.
Industry RankSector Rank
PE 203.81
Fwd PE 138.52
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

73.24% of the companies in the same industry are cheaper than 5Q5, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 100.78
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
5Q5's earnings are expected to grow with 43.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.38
PEG (5Y)N/A
EPS Next 2Y39.71%
EPS Next 3Y43.44%

0

5. Dividend

5.1 Amount

No dividends for 5Q5!.
Industry RankSector Rank
Dividend Yield N/A

SNOWFLAKE INC

FRA:5Q5 (9/5/2025, 7:00:00 PM)

189.54

+1.24 (+0.66%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)11-18 2025-11-18/amc
Inst Owners67.09%
Inst Owner ChangeN/A
Ins Owners2.7%
Ins Owner ChangeN/A
Market Cap63.24B
Analysts81.4
Price Target203.47 (7.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.77%
Min EPS beat(2)10.37%
Max EPS beat(2)29.18%
EPS beat(4)4
Avg EPS beat(4)34.24%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)33.59%
EPS beat(12)11
Avg EPS beat(12)78.78%
EPS beat(16)14
Avg EPS beat(16)120.99%
Revenue beat(2)2
Avg Revenue beat(2)2.31%
Min Revenue beat(2)1.47%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)2.2%
Min Revenue beat(4)1.2%
Max Revenue beat(4)3.15%
Revenue beat(8)8
Avg Revenue beat(8)1.65%
Revenue beat(12)11
Avg Revenue beat(12)1.26%
Revenue beat(16)15
Avg Revenue beat(16)1.75%
PT rev (1m)-0.74%
PT rev (3m)2.66%
EPS NQ rev (1m)8.54%
EPS NQ rev (3m)9.16%
EPS NY rev (1m)1.1%
EPS NY rev (3m)-3.02%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)1.78%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 203.81
Fwd PE 138.52
P/S 17.97
P/FCF 100.78
P/OCF 88.31
P/B 31.18
P/tB 81.09
EV/EBITDA N/A
EPS(TTM)0.93
EY0.49%
EPS(NY)1.37
Fwd EY0.72%
FCF(TTM)1.88
FCFY0.99%
OCF(TTM)2.15
OCFY1.13%
SpS10.55
BVpS6.08
TBVpS2.34
PEG (NY)5.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.83%
ROE -58.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.6%
FCFM 17.83%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 3.1
Debt/EBITDA N/A
Cap/Depr 51.65%
Cap/Sales 2.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z N/A
F-Score4
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)67.21%
Cap/Depr(5y)189.07%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.48%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%94.44%
EPS Next Y37.91%
EPS Next 2Y39.71%
EPS Next 3Y43.44%
EPS Next 5Y39.35%
Revenue 1Y (TTM)28.37%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%31.78%
Revenue Next Year25.9%
Revenue Next 2Y24.52%
Revenue Next 3Y25.09%
Revenue Next 5Y23.42%
EBIT growth 1Y-15.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year206.58%
EBIT Next 3Y84.52%
EBIT Next 5Y65.79%
FCF growth 1Y23.37%
FCF growth 3Y149.6%
FCF growth 5YN/A
OCF growth 1Y23.33%
OCF growth 3Y105.76%
OCF growth 5YN/A